Custom protein synthesis without cells: when a cell free expression route beats expression in a host, what it is good at, and where its limits actually sit
Cell-free synthesis makes protein in a reaction rather than in a living organism, which removes the constraints a cell imposes: the protein can be toxic, the reaction is open to additives, and results arrive in hours rather than days. It also removes what a cell provides, which is scale and the full machinery for folding and modification. This page covers where the trade is favourable and where expression in cells remains the better answer.
- the FDA cGMP rule that applies once material is destined for a drug product
- Part 211
- the ICH guideline on deriving and characterising cell substrates
- Q5D
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
Figures in this panel are the rules a contract biologics service is bought and audited against, named from the regulations and guidelines themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a services index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Where cell-free wins and loses
- Toxic and inhibitory proteins. A protein that kills the host cannot be made in one, and in an open reaction toxicity is irrelevant because nothing has to survive. This is the clearest case for cell-free and it is why the route exists in many laboratories at all.
- Speed for screening and variants. From template to protein in hours means variant panels, boundary screens and rapid checks become practical in a way that cell-based expression does not allow. Screening in cell-free and then producing the winner in cells is a common and sensible pattern.
- Non-natural amino acids and labelling. The reaction is open, so unusual amino acids, isotope labels and precise labelling schemes can be supplied directly rather than engineered into a host. This is a genuine capability advantage for structural and chemical biology work.
- Membrane proteins with a supplied environment. Detergents, nanodiscs or liposomes can be present as the protein is made, which helps membrane proteins that aggregate when expressed in cells. It is not a guarantee, but it is an option cells do not offer.
- Scale and cost are the limits. Cell-free reactions are expensive per unit of protein compared with fermentation, and scaling them is a different exercise from growing more cells. For quantity, cell-based expression remains the economical route.
Choosing a system
Bacterial lysate systems are the cheapest and highest yielding and offer no eukaryotic modification. Wheat germ and insect systems fold complex eukaryotic proteins better at lower yield. Reconstituted systems built from purified components give the cleanest background at the highest cost. The protein decides.
Ask providers for their yield range on proteins comparable to yours rather than a headline figure, since cell-free yields vary between targets more than most catalogue numbers suggest.
What you still have to do
The reaction produces protein in a complex mixture, so purification is still required and the lysate background is different from a cell lysate background. Plan the purification route with the system in mind.
Confirm activity rather than assuming it. Folding in a cell-free reaction is not guaranteed, and a protein that is present on a gel is not necessarily a protein that works.
Common questions
- When is cell-free protein synthesis the right choice?
- For toxic proteins, for rapid screening of many variants, where non-natural amino acids or precise labelling are needed, and for membrane proteins that can be given a lipid or detergent environment as they are made.
- Why not use cell-free for everything?
- Cost per unit of protein is far higher than fermentation and scaling is a different problem from growing more cells. For quantity, expression in cells remains the economical route.
- Which cell-free system should I use?
- Bacterial lysates for yield and cost with no eukaryotic modification; wheat germ or insect systems for complex eukaryotic folding at lower yield; reconstituted systems for the cleanest background at the highest price.
- Does cell-free protein fold correctly?
- Not automatically. Folding must be confirmed by an activity or structural assessment, exactly as with any other expression route. Presence on a gel is not evidence of function.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/custom-protein-synthesis/.